SCICANN THERAPEUTICS INC has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are BIOCARE CO LTD, DAICHO KIKAKU KK and NEUROCENTRIA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Specific use of cosmetics | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Koren Zohar | 12 |
Publication | Filing date | Title |
---|---|---|
WO2020194237A1 | Cannabinoid compositions and use thereof | |
US2019365702A1 | Compositions comprising a cannabinoid and spilanthol | |
WO2019159176A1 | Compositions and methods for treatment of neurodegenerative diseases | |
WO2019155337A1 | Compositions comprising a cannabinoid and punicalagin and methods of use thereof | |
CA3029528A1 | Compositions comprising a cannabinoid and spilanthol | |
AU2018330807A1 | Compositions comprising a cannabinoid and spilanthol |